2023 in Rear Mirror View: Top Performers From My Global Healthcare Coverage Universe
âDespite ongoing recovery and fading effect of the COVID-19, healthcare companies had varying performances in 2023. From my coverage, the top...
762 Views
APAC Healthcare Weekly (November 2) â Takeda, Eisai, Wuxi AppTec, Celltrion, CSL, PharmaEssentia
Takeda and Eisai witnessed clinical trials setback. Wuxi AppTec is selling China-based CRO subsidiaries. CSL is delaying demerger of CSL Seqirus....
746 Views
APAC Healthcare Weekly (October 19) â Hansoh, Leads Biolabs, Chugai, SanBio, Celltrion, Samsung Bio
Hansoh and Leads Biolabs bag global outlicensing deals. Chugaiâs partner Lilly announced positive P3 result for orforglipron. Celltrion launched...
878 Views
APAC Healthcare Weekly (September 14)âCSPC Pharm, TransThera, Samsung Bio, Daiichi Sankyo, Sun Pharm
CSPC Pharmaâs NDA for Anbenitamab injection has been accepted in China. TransThera got trial approval for lead candidate. Samsung Bio signed $1.3B...
571 Views
Korean Government Confirms Visa-Free Entry of Group Tourists from China to South Korea
We provide a list of top 20 companies in Korea that are key beneficiaries of the no visa policy for group tour visitors from China to South Korea.
369 Views